| 8.30-9.00 | Registration of delegates and speakers | |
| 9.00-9.15 | Welcome addresses
Director of CDR Dean, Faculty of Medicine Sciences Vice-Chancellor |
|
| Over-view of the research collaborations
Chairpersons: Dr. Geethani Galagoda, Head of Laboratory, LHD |
||
| 9.15 – 9.30 | TBA | Mike Catton: Director of VIDRL |
| 9.30 – 10.15 | TBA | Julian Druce: Head, Virus Identification Laboratory, VIDRL |
| 10.15 – 10.45 | Epidemiology of dengue in Sri Lanka | Hasitha Tissera
Director, National Dengue Control Unit |
| 10.45 – 11.15 | Morning tea | |
| Identification strategies of viral diseases
Chairpersons: Prof. Ng Mah Lee: NUS, Singapore |
||
| 11.15- 11.45 | WHO Global Flavivirus molecular panel | Torsten Theis
Senior Hospital Scientist RCPAQAP Biosecurity, Australia |
| 11.45 – 12.15 | Nanopore technology in viral identification | Lakmal Jayasinghe
Director, Oxford Nanopore Technologies, UK |
| 12.15 – 12.45 | Virus identification strategies | Julian Druce. Head, Virus Identification Laboratory, VIDRL |
| 12.45- 1.15 | Role of Serology in virus identification | Suellen Nicholson. Head of Infectious Diseases Serology Laboratory, VIDRL |
| 1.15 – 2.15
|
Lunch
|
|
| Other emerging viral disease
Chairperson: Dr. Kushlani Jayathileke, Consultant Microbiologist and President, Sri Lanka College of Microbiologists |
||
| 2.15 – 2.45 | Overview on zoonotic diseases of human importance | Hans Netter
Adjunct Medical Scientist, VIDRL |
| 2.45 – 3.15 | Unusual presentations in dengue | Ananda Wijewickrama.
Senior Consultant Physician, National Institute of Infectious Diseases |
| 3.15-3.45 | Dengue as a cause of necrotising panophthalmitis | Chameera Bandara. Oculoplasty surgeon, Eye Hospital, Colombo |
| 3.45 – 4.15 | Hanta virus infection in Sri Lanka | Rohitha Muthugala Consultant Virologist, Teaching Hospital Kandy |
| 4.15-4.45 | Tea | |
| Poster sessions/breakout sessions with speakers
|
||
| 4.45 – 5.45 | Poster sessions and breakout sessions with speakers | |
| 21st September 2018 | ||
| Pathogenesis of dengue and flavivirus infections
Chairperson: Dr. Rajiva de Silva, Consultant Immunologist, Head, Immunology Laboratory, MRI |
||
| 9.00 – 9.30 | Immunology of dengue infection | Katja Fink. Principal Investigator, Singapore Immunology Network |
| 9.30 – 10.00 | NS1 antibody responses to dengue | Neelika Malavige. Centre for Dengue Research |
| 10.00 – 10-30 | Infectious causing GBS | Umapathy Thirugnanam. National Neuroscience Institute, Singapore |
| 10.30 – 11.00
|
Morning Tea | |
| Flavivirus infections and Vaccines
Chairperson: Prof Sirimali Fernando, Chairperson, National Science Foundation |
||
| 11.00 – 11.30 | Designer Dengue Vaccine Candidate: Neutralisation without Enhancement | Navin Khanna. Group leader, Recombinant gene products, ICGEB, New Delhi |
| 11.30 – 12.00 | JE vaccine | Vijaya Sachidanandam. Group leader, Recombinant gene products, ICGEB, New Delhi |
| 12.30-1.00 | Pathogenesis of Zika | Fok-Moon Lum, Senior Scientist, A star, Singapore |
| 1.00-2.00 | Lunch | |
| Other viral emerging disease
Chairperson: |
||
| 2.00-2.30 | Polio in sewage | Mike Catton, Director VIDRL |
| 2.30-3.15 | Strengthening research partnerships. Breakout sessions in 4 groups | |
| 3.15-3.30 | Concluding remarks | Mike Catton. Director VIDRL |
| 3.30 – 4.00 | Afternoon tea | |
| Poster sessions/breakout sessions with speakers
|
||
| 4.00 – 5.30 | Poster sessions and breakout sessions with speakers
|
|
